| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |